0001104659-26-127191.txt : 20261113 0001104659-26-127191.hdr.sgml : 20261113 20261113165956 ACCESSION NUMBER: 0001104659-26-127191 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261113 DATE AS OF CHANGE: 20261113 EFFECTIVENESS DATE: 20261113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neuvivo, Inc. CENTRAL INDEX KEY: 0002154992 ORGANIZATION NAME: EIN: 850827322 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-604762 FILM NUMBER: 261553769 BUSINESS ADDRESS: STREET 1: 2100 GENG RD., SUITE 210 CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: (650) 440-6766 MAIL ADDRESS: STREET 1: 2100 GENG RD., SUITE 210 CITY: PALO ALTO STATE: CA ZIP: 94303 D 1 primary_doc.xml X0708 D LIVE 0002154992 Neuvivo, Inc. 2100 GENG ROAD SUITE 210 PALO ALTO CA CALIFORNIA 94303 (650) 440-6766 DELAWARE Neuviva, Inc. None Corporation true Michael McGrath 2100 Geng Road Suite 210 Palo Alto CA CALIFORNIA 94303 Executive Officer Director Virit Vichitvadakan 2100 Geng Road Suite 210 Palo Alto CA CALIFORNIA 94303 Director Pornsit Poovanakijjakorn 2100 Geng Road Suite 210 Palo Alto CA CALIFORNIA 94303 Director Robert Baffi 2100 Geng Road Suite 210 Palo Alto CA CALIFORNIA 94303 Director John Curnutte 2100 Geng Road Suite 210 Palo Alto CA CALIFORNIA 94303 Director Pharmaceuticals Decline to Disclose 06b false 2026-10-30 false true true true false 0 9500000 1384615 8115385 false 1 0 0 416000 Proceeds of the offering will be used for general corporate purposes including salary paid to the Chief ExecutiveOfficer. false Neuvivo, Inc. /s/ Michael McGrath Michael McGrath Chief Executive Officer 2026-11-13